WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 10 fonti

FDA shuffles top drug, biologics leaders in latest shakeup

The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, days after the departure of former commissioner Marty Makary.

Raccontata dabiopharmadive.comapnews.comaxios.comthedispatch.comfiercepharma.comnbcnews.comcnbc.combenzinga.comeconomictimes.indiatimes.comforbes.com

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
cnbc.comStai leggendo1 mesi fa

FDA shuffles top drug, biologics leaders in latest shakeup

The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, days after the departure of former commissioner Marty Makary.

originale
economictimes.indiatimes.com1 mesi fa

FDA drug center head fired after commissioner's exit, replaced by Davis

The U.S. Food and Drug Administration's drug center sees a leadership change as acting head Tracy Beth Hoeg departs, replaced by deputy Michael Davis. This follows Commissioner Marty Makary's exit amid agency-wide…

Leggi questa versione → originale
biopharmadive.com1 mesi fa

FDA’s leadership void leaves biotech with renewed ‘uncertainty’

Marty Makary's resignation leaves the agency with temporary directors in three top positions, and a number of newly instituted policies with an unclear future.

Leggi questa versione → originale
apnews.com1 mesi fa

FDA official who scrutinized COVID shots and antidepressants is out in latest shake-up

The Food and Drug Administration's top drug official is leaving in the latest shake-up at the powerful health agency. Dr.

Leggi questa versione → originale
fiercepharma.com1 mesi fa

After Makary departure, CDER chief Tracy Beth Høeg likely headed out at FDA: report

With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be heading for the exit at the FDA.  | With the ink barely dry on outgoing commissioner Marty Makary’s resignation,…

Leggi questa versione → originale
forbes.com1 mesi fa

Why FDA Leadership Changes Matter For Every American

The FDA commissioner influences vaccines, medicines, food safety, nicotine regulation, and public trust. Here’s how leadership changes at the FDA can affect everyday life.

Leggi questa versione → originale

Timeline cronologica

  1. mercoledì 13 maggio 2026·biopharmadive.com

    FDA’s leadership void leaves biotech with renewed ‘uncertainty’

    Marty Makary's resignation leaves the agency with temporary directors in three top positions, and a number of newly instituted policies with an unclear future.

  2. mercoledì 13 maggio 2026·apnews.com

    FDA chief's resignation widens a leadership gap at the nation's health department

    Dr. Marty Makary's resignation from his post atop the Food and Drug Administration is widening a leadership gap that already existed at the U.S.

  3. mercoledì 13 maggio 2026·axios.com

    Pharma leaders hope next FDA head calms waters

    They called for stability and predictability at the agency at Axios' Future of Health summit.

  4. giovedì 14 maggio 2026·thedispatch.com

    Marty Makary’s Turbulent Tenure at FDA Comes to an End

    Brought in as an agency critic, the commissioner drew fire from drug developers and abortion foes.

  5. giovedì 14 maggio 2026·fiercepharma.com

    Biopharma leaders rally behind Pazdur for FDA commissioner pick. But does he want the role?

    With the FDA now rudderless following the revelation that commissioner Marty Makary, M.D., is stepping down, voices across biopharma have joined in support of the FDA’s former top…

  6. venerdì 15 maggio 2026·fiercepharma.com

    After Makary departure, CDER chief Tracy Beth Høeg likely headed out at FDA: report

    With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be heading for the exit at the FDA.  | With the ink barely dry on outgoing…

  7. sabato 16 maggio 2026·nbcnews.com

    FDA leadership shake-up continues with departure of top drug regulator

    Dr. Tracy Beth Høeg is leaving her role as head of the FDA’s Center for Drug Evaluation and Research, just days after FDA chief Marty Makary resigned.

  8. sabato 16 maggio 2026·cnbc.com

    FDA shuffles top drug, biologics leaders in latest shakeup

    The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, days after the departure of former commissioner Marty Makary.

  9. sabato 16 maggio 2026·apnews.com

    FDA official who scrutinized COVID shots and antidepressants is out in latest shake-up

    The Food and Drug Administration's top drug official is leaving in the latest shake-up at the powerful health agency. Dr.

  10. sabato 16 maggio 2026·benzinga.com

    FDA Drug Chief Tracey Hoeg Fired Days After After Marty Makary's Exit— Says Order Came From 'Way Above' -

    Tracey Beth Hoeg was fired as FDA drug division chief amid a broader Trump administration shake-up at the health department.

  11. sabato 16 maggio 2026·economictimes.indiatimes.com

    FDA drug center head fired after commissioner's exit, replaced by Davis

    The U.S. Food and Drug Administration's drug center sees a leadership change as acting head Tracy Beth Hoeg departs, replaced by deputy Michael Davis. This follows Commissioner…

  12. lunedì 18 maggio 2026·forbes.com

    Why FDA Leadership Changes Matter For Every American

    The FDA commissioner influences vaccines, medicines, food safety, nicotine regulation, and public trust. Here’s how leadership changes at the FDA can affect everyday life.